Skip to main content
. 2026 Sep 6;18(9):980. doi: 10.3390/v18090980
APC Antigen-presenting cell
BART BamH1-A rightward transcript
BL Burkitt lymphoma
BTK Bruton’s tyrosine kinase
CAR Chimeric antigen receptor
CCRT Concurrent chemoradiotherapy
CHAF1A Chromatin assembly factor 1 subunit A
CHL Chronic high viral load
CTLA-4 Cytotoxic T lymphocyte-associated protein 4
DLBCL Diffuse large B-cell lymphoma
DNA Deoxyribonucleic acid
EBER EBV-encoded RNA
EBNA1 Epstein–Barr nuclear antigen 1
EBV Epstein–Barr virus
GC Gastric cancer
HIV Human immunodeficiency virus
HL Hodgkin lymphoma
ISH In situ hybridization
JAK Janus kinase
LAG-3 Lymphocyte activation gene 3
LMP Latent membrane protein
mIR MicroRNA
MMAE Monomethyl auristatin E
mRNA Messenger RNA
NHL Non-Hodgkin lymphoma
NKTL NK/T-cell lymphoma
NPC Nasopharyngeal carcinoma
PBMC Peripheral blood mononuclear cell
PD-1 Programmed cell death protein 1
PD-L1 Programmed death ligand 1
PTEN Phosphatase and tensin homolog
PTLD Post-transplant lymphoproliferative disorder
R/R Relapsed or refractory
RNA Ribonucleic acid
SMARCA4 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A, member 4
SNP Single-nucleotide polymorphism
sZEBRA Soluble form of the EBV ZEBRA protein
TIL Tumor-infiltrating lymphocyte
TMB Tumor mutational burden